HaloVax

Business Data, Corporate Office and Headquarter Address

About

HaloVax is Pharmaceuticals in United States that focus on developer business. Founded in 2020. They cover business area such as developer, vaccine prospect.

Business Type

Pharmaceuticals

Country

United States

Founded

2020
( 6 years old in 2026 )

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

1 Rockefeller Plaza
Suite 1039
New York, NY 10020
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developervaccine prospect

* We use standard office opening hours in near HaloVax's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

HaloVax Frequently Asked Questions

What or who is HaloVax?

HaloVax is Pharmaceuticals business from United States that founded in 2020 (6 years old in 2026), HaloVax business is focusing on Developer.

Where is HaloVax headquarter and corporate office address?

HaloVax headquarter office and corporate office address is located in 1 Rockefeller Plaza Suite 1039 New York, NY 10020 United States.

Where is HaloVax country origins?

HaloVax was founded in United States.

What is Developer business focus on?

In 2026, HaloVax is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with HaloVax, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.